Skip to content

The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis Patients

The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis Patients

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00179140
Enrollment
26
Registered
2005-09-15
Start date
2002-11-30
Completion date
2006-02-28
Last updated
2015-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease

Brief summary

The objective of this study is to determine how protein supplementation, with or without exercise, affects functional capacity, strength, body composition, and physical activity in hemodialysis patients.

Interventions

oral administration of protein supplement (Nepro) during hemodialysis; every other day, 3 days per week for 6 months; Nepro is a lactose-free formula that contains a total of 960 kilocalories: 132.8 kilocalories from protein, 412.8 kilocalories from carbohydrates, and 412.8 kilocalories from fat

BEHAVIORALexercise

either before or during hemodialysis, patients will perform a leg press exercise; every other day, 3 days per week, for 6 months

Sponsors

Vanderbilt University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* On hemodialysis for more than 3 months, on a thrice weekly hemodialysis program; * Adequately dialyzed (Kt/V \> 1.4). * Age \> 18 years old. * Properly functioning AV Graft

Exclusion criteria

* Patients unable to perform exercise due to cardiovascular disease, osteoarthritis, etc. * Pregnant women. * Severe unstable underlying disease besides commonly associated with ESRD. Cardiac patients that are stable will be included. * Patients hospitalized within the last month prior to the study. * Patients will not perform the MRI if contraindication as determined using the VUMC MRI Procedure Screening Form (attached) or prior claustrophobic reaction in an MRI scanner.

Design outcomes

Primary

MeasureTime frame
increase in lean body mass13 months

Secondary

MeasureTime frame
improve physical functioning13 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026